Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
  • Rating
    Not Rated
  • Minimum Investment
    1000
  • NAV (Net Asset Value)
    N/A
  • AUM (Fund size)
    520 Cr
  • Created on
    5 June 2025
Fund Ranking
#
/ 16 in Sectoral-Pharma
Risk Level

Very High

Loading...
Returns
Trailing Return
Rolling Return
  • 6 Month
    12.5%
  • 1 Year
    10.4%
  • 3 Year (CAGR)
    -
  • All Time (CAGR)
    6.3%
Category Return
  • 6 Month
    16.8%
  • 1 Year
    18.1%
  • 3 Year (CAGR)
    21.8%
  • All Time (CAGR)
    17.2%
Asset Allocation
  • Equity
    96.6%
  • Debt
    1.0%
  • Other
    2.4%
Top 5 Holdings
Top 5 Sectors
  • Apollo Hospitals Enterprise
    5.35%
  • Astrazeneca Pharma India
    4.05%
  • Aurobindo Pharma
    3.04%
  • Cipla
    1.13%
  • Dr. Reddy's Laboratories
    1.11%
Fund Information
  • Expense Ratio
    2.74%
  • Exit Load
    Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
  • Lock-In Period
    No Lock-In

Managed By

Sanjay Chawla
June 2025 - Present
Ankeet Pandya
July 2026 - Present
Rohan Korde
May 2026 - Present
Risk & Return Ratio
  • Sharpe Ratio
    0.00
  • Standard Deviation
    0.00
  • Alpha
    0.00
  • Beta
    0.00